Paclitaxel and docetaxel. Innovation, but at what cost?
Lønning
P E
PE
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000191:economics*; D003365:Costs and Cost Analysis; D000077143:Docetaxel; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use*; D043823:Taxoids